Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP294554.RAw_9RDw8PoXYrGTyfdS6CNnRwUObUlrVekKPWGJRfKj8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP294554.RAw_9RDw8PoXYrGTyfdS6CNnRwUObUlrVekKPWGJRfKj8130_assertion type Assertion NP294554.RAw_9RDw8PoXYrGTyfdS6CNnRwUObUlrVekKPWGJRfKj8130_head.
- NP294554.RAw_9RDw8PoXYrGTyfdS6CNnRwUObUlrVekKPWGJRfKj8130_assertion description "[Treatment of CD40 or BCR activated CLL cells with PCI-32765 results in inhibition of BTK tyrosine phosphorylation and also effectively abrogates downstream survival pathways activated by this kinase including ERK1/2, PI3K, and NF-?B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP294554.RAw_9RDw8PoXYrGTyfdS6CNnRwUObUlrVekKPWGJRfKj8130_provenance.
- NP294554.RAw_9RDw8PoXYrGTyfdS6CNnRwUObUlrVekKPWGJRfKj8130_assertion evidence source_evidence_literature NP294554.RAw_9RDw8PoXYrGTyfdS6CNnRwUObUlrVekKPWGJRfKj8130_provenance.
- NP294554.RAw_9RDw8PoXYrGTyfdS6CNnRwUObUlrVekKPWGJRfKj8130_assertion SIO_000772 21422473 NP294554.RAw_9RDw8PoXYrGTyfdS6CNnRwUObUlrVekKPWGJRfKj8130_provenance.
- NP294554.RAw_9RDw8PoXYrGTyfdS6CNnRwUObUlrVekKPWGJRfKj8130_assertion wasDerivedFrom befree-20150227 NP294554.RAw_9RDw8PoXYrGTyfdS6CNnRwUObUlrVekKPWGJRfKj8130_provenance.
- NP294554.RAw_9RDw8PoXYrGTyfdS6CNnRwUObUlrVekKPWGJRfKj8130_assertion wasGeneratedBy ECO_0000203 NP294554.RAw_9RDw8PoXYrGTyfdS6CNnRwUObUlrVekKPWGJRfKj8130_provenance.